NCT06698770

Brief Summary

Our online, survey-based experiment will include 2,400 adults who are 65-years and older (n=1,200 each from United States and Australia). Each participant will be asked to give their opinions on a hypothetical patient scenario that has been developed by our diverse team in partnership with our stakeholder organizations.This work is expected to significantly contribute to our understanding of how older adults make decisions about deprescribing medications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,420

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2024

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

November 19, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 21, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2025

Completed
Last Updated

September 26, 2025

Status Verified

November 1, 2024

Enrollment Period

3 months

First QC Date

November 19, 2024

Last Update Submit

September 24, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Preference regarding starting medication

    Response to statement, "Based on what you have read so far, what would you prefer to do with this diabetes medicine?" on a 6-point Likert scale with scale anchors 1=Strongly prefer not to start medicine and 6=Strongly prefer to start medicine

    1 year

  • Stopping medication

    Response to statement, "Based on what you have read so far, what would you prefer to do with this diabetes medicine?" on a 6-point Likert scale with scale anchors 1=Strongly prefer not to continue and 6=Strongly prefer to stop

    1 year

Study Arms (4)

Start medication - Lower chance of future health problems

EXPERIMENTAL

Participants read a hypothetical scenario where a doctor recommends starting a new medication to lower their chances of experiencing significant health problems.

Other: Anticipated long-term use of medicationOther: Period re-evaluation of medication

Start medication - Higher risk without medication

EXPERIMENTAL

Participants read a hypothetical scenario where a doctor recommends starting a new medication because they could experience a higher risk of serious health problems without it

Other: Anticipated long-term use of medicationOther: Period re-evaluation of medication

Stop medication - Lack of benefit

EXPERIMENTAL

Participants read a hypothetical scenario where a doctor suggests stopping the medication due to a lack of benefit.

Other: Anticipated long-term use of medicationOther: Period re-evaluation of medication

Stop medication - Potential for harm

EXPERIMENTAL

Participants read a hypothetical scenario where a doctor suggests stopping the medication due to the potential for harm.

Other: Anticipated long-term use of medicationOther: Period re-evaluation of medication

Interventions

In this hypothetical scenario, the doctor anticipates that the participant will take this medication for the rest of their life.

Start medication - Higher risk without medicationStart medication - Lower chance of future health problemsStop medication - Lack of benefitStop medication - Potential for harm

In this hypothetical scenario, the doctor anticipates that the participant will take this medication for the rest of their life but will periodically re-evaluate the benefits and risks of the medication.

Start medication - Higher risk without medicationStart medication - Lower chance of future health problemsStop medication - Lack of benefitStop medication - Potential for harm

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • years and older and resides in Australia or the United States

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor of Clinical Pharmacy and Associate Chair, Clinical Pharmacy, College of Pharmacy

Study Record Dates

First Submitted

November 19, 2024

First Posted

November 21, 2024

Study Start

November 1, 2024

Primary Completion

January 30, 2025

Study Completion

January 30, 2025

Last Updated

September 26, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations